EPCAM and breast carcinoma: In 100 early breast cancer patients, the prognostic significance of the level of one of the main EMT transcription factors, TWIST1, was also investigated together with some stem cell transcripts, such as CD24, CD44, and ALDH1, in enriched EpCAM+ CTCs, obtaining promising results [51,103,104].